🟢 Nanobiotix is trading 6.24% up in pre-market as biotech ETF XBI rises

Nanobiotix is trading at $27.44, up 6.24% in pre-market, with biotech-sector strength supporting a sector-led explanation.

• Biotech ETF XBI is up 3.64% pre-market, while broader index futures are lower.
• No new company-specific catalyst was identified for October 22; the latest full-cohort Phase 1 results were announced September 14, not overnight.
• The move follows gains of 7.00% and 14.52% in the two prior sessions.